Adhesion molecules in patients with severe atherothrombotic stroke

Cover Page

Abstract

Abstract

Introduction. Atherothrombotic stroke represents 34% of stroke cases among all the subtypes of ischemic stroke. Adhesion molecules are proteins associated with the basal membrane. They contribute to the intensification of adhesion processes, hyperaggregation of blood cells and microcirculation disorders.

Objective. To investigate the blood levels of adhesion molecules in patients with severe atherothrombotic stroke.

Materials and methods. For the study, we recruited 21 patients (mean age, 67 [61; 73] years) with atherothrombotic stroke in the  carotid system who were observed for the initial 48 hours since the development of neurological symptoms. The patients were categorized as severe stroke based on the total NIHSS score (Me 15 [14; 18]) at the time of admission. The spectrum of soluble cellular adhesion molecules as immunological markers of endothelial dysfunction was studied.

Results. Increased levels of sICAM-1, sPECAM-1, sР-selectin, sЕ-selectin and sVCAM-1 were revealed at the beginning of the acute period of atherothrombotic stroke. By the day 21, a decrease of sPselectin, sE-selectin and sVCAM-1 was seen, and this phenomenon was probably caused by effects of blood antiplatelet therapy and statins on cellular adhesion. Positive correlation was established between the VCAM-1 during the first 48 hours of atherothrombotic stroke and the severity of neurologic deficit by the day 21. In the subgroup of patients with lethal outcomes, sICAM-1 and sVCAM-1 levels were higher in comparison with patients with severe disability.

Conclusion. Elevated expression of sVCAM-1 in the first 48 hours of atherothrombotic stroke is associated with severe neurologic deficit by the day 21 of stroke. The high levels of sICAM-1 and sVCAM-1 upon admission may be regarded as risk factors for lethal outcomes.

About the authors

Fatima R. Okhtova

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Author for correspondence.
Email: center@test.ru
Russian Federation

Vladimir N. Mikhal'chenko

Spasokukotskiy Clinical Hospital

Email: center@test.ru
Russian Federation

Marina Yu. Maksimova

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Email: center@test.ru
Russian Federation

References

  1. References
  2. Suslina Z.A., Gulevskaya T.S., Maksimova M.Yu., Morgunov V.A. Narusheniya mozgovogo krovoobrashcheniya: diagnostika, lechenie, profilaktika [Cerebrovascular diseases: diagnosis, treatment, prevention]. Moscow: MEDpress-inform, 2016. 536 p. (in Russ.)
  3. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170(2): 191-203. PMID: 14612198 doi: 10.1016/S0021-9150(03)00097-2
  4. Nuotio K., Lindsberg P.J., Carpén O. et al. Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology 2003; 60(12): 1890-9. PMID: 12821729. doi: 10.1212/01.WNL.0000065914.33177.9E
  5. Rodrigues S.F., Granger D.N. Blood cells and endothelial barrier function. Tissue Barriers. 2015; 3(1-2): e978720 PMID: 25838983 doi: 10.4161/21688370.2014.978720.
  6. Rallidis L.S., Zolindaki M.G., Vikelis M. et al. Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke. Int J Cardiol. 2009; 132(2): 216-20. PMID: 18191248 doi: 10.1016/j.ijcard.2007.11.031.
  7. Prugger C., Luc G., Haas B. et al.; PRIME Study Group. Multiple biomarkers for the prediction of ischemic stroke: the PRIME study. Arterioscler Thromb Vasc Biol. 2013; 33(3): 659-66. PMID: 23329137 doi: 10.1161/ATVBAHA.112.300109.
  8. Cherian P.., Hankey G.J., Eikelboom J.W. et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003; 34(9): 2132-7. PMID: 12907813 doi: 10.1161/01.STR.0000086466.32421.F4.
  9. Jenny N.S., Arnold A.M., Кuller L.H. et al. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults. J Thromb Haemost 2006; 4(1): 107-113. PMID: 16409459. doi: 10.1111/j.1538-7836.2005.01678.x
  10. Komel'kova L.V., Ionova V.G. [Adhesion molecules and platelet-vascular hemostasis in patients with internal carotid artery stenosis of atherosclerotic origin]. Tromboz, gemostaz i reologiya 2011; 1(45): 53-60. (in Russ.)
  11. Wang J.H., Zhang Y.W., Zhang P. et al. CD40 ligand as a potential biomarker for atherosclerotic instability. Neurol Res. 2013; 35(7): 693-700 PMID: 23561892 doi: 10.1179/1743132813Y.0000000190.
  12. Lukasik M., Dworacki G., Kufel-Grabowska J. et al. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. Thromb Haemost. 2012; 107(2): 346-55. PMID: 22234746. doi: 10.1160/TH11-05-0345
  13. Lim H.S., Blann A.D., Lip G.Y. Soluble CD40 ligand, soluble P-selectin interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109(21): 2524-8. PMID: 15136493. doi: 10.1161/01.CIR.0000129773.70647.94
  14. Seljeflot I., Tonstad S., Hjermann I., Arnesen H. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis 2002; 162(1): 179-85.PMID: 11947912. doi: 10.1016/S0021-9150(01)00696-7
  15. Price C.J., Warburton E.A., Menon D.K. Human cellular inflammation in the pathology of acute cerebral ischemia. J Neurol Neurosurg Psychiatry 2003; 74: 1476-1484. PMID: 14617701
  16. Frijns C.J., Kapppelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002; 33: 2115-2122. PMID: 12154274.
  17. Huang J., Upadhyay U.M., Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006; 66(3): 232-45. PMID: 16935624. doi: 10.1161/01.STR.0000021902.33129.69
  18. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003; 62(2): 127-36. PMID: 12578222. doi: 10.1093/jnen/62.2.127
  19. Wu F., Liu L., Zhou H. Endothelial cell activation in central nervous system inflammation. J Leukoc Biol. 2017; 101(5): 1119-1132. PMID: 28196850 doi: 10.1189/jlb.3RU0816-352RR.
  20. Blann A., Kumar P., Krupinski J. et al. Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. Blood Coagul Fibrinolysis 1999; 10(5): 277-84. PMID: 10456619.
  21. Hwang S.J., Ballantyne C.B., Sharrett A.R. et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incidental coronary heart disease cases. The Atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 4219-4225. PMID: 9416885.
  22. De Caterina R., Basta G., Lazzerini G. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17(11): 2646-54. PMID: 9409238.
  23. Blum A, Khazim K, Merei M et al. The stroke trial - can we predict clinical outcome of patients with ischemic stroke by measuring soluble cell adhesion molecules (CAM)? Eur Cytokine Netw. 2006; 17(4): 295-8. PMID: 17353165.
  24. Maksimova M.Yu, Komel'kova L.V., Okhtova F.R. [Factors of intercellular interaction in acute ischemic stroke]. Zh Nevrol Psikhiatr Im S.S. Korsakova. 2014;114(2):15-20. PMID: 24662339. (In Russ.)
  25. Richard S., Lagerstedt L., Burkhard P.R. et al. E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases. J Inflamm (Lond). 2015; 12: 61. PMID: 26543408 doi: 10.1186/s12950-015-0106-z.
  26. Wang J.Y., Zhou D.H., Li J., Zhang M. et al. Association of soluble intercellular adhesion molecule 1 with neurological deterioration of ischemic stroke: The Chongqing Stroke Study.Cerebrovasc Dis. 2006; 21(1-2): 67-73. PMID: 16330866. doi: 10.1159/000090005
  27. Supanc V., Biloglav Z., Kes V.B., Demarin V. Role of cell adhesion molecules in acute ischemic stroke. Ann Saudi Med. 2011; 31(4): 365-70. PMID: 21808112 doi: 10.4103/0256-4947.83217.
  28. Clark W.M., Coull B.M., Briley D.P. et al. Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol. 1993; 44: 123–25. PMID: 8098717. doi: 10.1016/0165-5728(93)90275-4
  29. Shabalina A.A. Gemostaz i biokhimicheskie markery povrezhdeniya tkani mozga pri aterotromboticheskom i lakunarnom podtipakh ishemicheskogo insul'ta [Hemostasis and biochemical markers of brain tissue damage in atherothrombotic and lacunar subtypes of ischemic stroke] avtor. Dis….kand.med.nauk. Moscow. 2009: 29 p. (In Russ.)
  30. Bitsch A., Kleine W., Murtada L. et al. A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998; 29: 2129–35. PMID: 9756594. doi: 10.1161/01.STR.29.10.2129
  31. Kozuka K., Kohriyama T., Nomura E. et al. Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype. Atherosclerosis 2002; 161(1): 161-8. PMID: 11882328. doi: 10.1016/S0021-9150(01)00635-9

Statistics

Views

Abstract: 1188

PDF (Russian): 674

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2018 Okhtova F.R., Mikhal'chenko V.N., Maksimova M.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies